Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-14-027129

CFO & COO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · CFO & COO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-06-28 Exercise or conversion : show line 1 in the form +100,000 $1.25 $125,000 1,112,332 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-06-28 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −100,000 0 D
Loading xslF345X03/doc1.xml…